Product Information
GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.3913 per ML under NDC 00713085004. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713085004
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GRISEOFULVINApproval Type
Generic (ANDA)
FDA Application
ANDA065438FDA Approved
10/8/2010
TE Code
AB
On Market Since
11/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3913 per ML |
|---|---|
| All-time high | $1.0444 (Oct 16, 2024) |
| All-time low | $0.3348 (Apr 22, 2026) |
| 52-week high | $0.4277 |
| 52-week low | $0.3348 |
| Median price | $0.4104 |
| Average price | $0.5105 |
| Largest weekly change | +65.1% (Feb 21, 2024) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Griseofulvin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tubulin Inhibiting Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Cosette Pharmaceuticals, Inc., is $0.3913 per ML (NDC 00713085004), effective Sep 30, 2026.
How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has declined 4.7%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?
Since Feb 22, 2023, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.3348 (Apr 22, 2026) to a high of $1.0444 (Oct 16, 2024), with a median of $0.4104 per ML.
Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GRISEOFULVIN 125 MG/5 ML SUSP, is $0.2521 per ML — about 36% below GRISEOFULVIN 125 MG/5 ML SUSP.
Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?
GRISEOFULVIN 125 MG/5 ML SUSP (NDC 00713085004) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.